The mRNA vaccine, known as BTN116, developed by the German biotechnology company BioNTech, is the first of its kind and has entered phase 1 clinical trials in seven countries.
1st lung cancer vaccine trials launch, powered by COVID mRNA technology
3 weeks ago 18 
